BioCryst Pharmaceuticals, Inc. Inventory

Inventory of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Inventory growth rates and interactive chart. Inventory is the term for the goods available for sale and raw materials used to produce goods available for sale. Inventory represents one of the most important assets of a business because the turnover of inventory represents one of the primary sources of revenue generation and subsequent earnings for the company's shareholders.

Highlights and Quick Summary

  • Inventory for the quarter ending September 30, 2022 was $27 Million (a 15.57% increase compared to previous quarter)
  • Year-over-year quarterly Inventory increased by 71.1%
  • Annual Inventory for 2021 was $15.8 Million (a 124.34% increase from previous year)
  • Annual Inventory for 2020 was $7.04 Million (a 326.86% increase from previous year)
  • Annual Inventory for 2019 was $1.65 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Inventory of BioCryst Pharmaceuticals, Inc.

Most recent Inventoryof BCRX including historical data for past 10 years.

Interactive Chart of Inventory of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Inventory for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $27.02 $23.38 $16.14 –
2021 $15.79 $13.66 $9.85 $5.11 $15.79
2020 – $7.04 $6.24 $5.23 $7.04
2019 $1.78 $1.78 $1.0 $0.6 $1.65
2018 $1.65 $0.82 $0.22 $0.01 $1.65
2017 – – $1.31 $0.66 $0.5
2016 $0.5 $2.23 $1.95 $1.95 $0.5
2015 – $1.61 $1.31 $1.21 $1.61
2014 – – – $0.68 $0.68
2012 $0.26 $0.26 $0.26 – –

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com